Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 9, 2011, Pages 1272-1273

  Lawn, Stephen D ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIVIRAL THERAPY; BACTERIUM DETECTION; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DRUG USE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INFECTION RATE; LETTER; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK REDUCTION; SCREENING TEST; SOCIAL STATUS; SPUTUM SMEAR; TREATMENT INDICATION; TUBERCULOSIS; TUBERCULOSIS CONTROL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; TUBERCULOSIS;

EID: 80051695683     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0407     Document Type: Letter

References (5)

1. Lawn S D, Wood R, De Cock K M, Kranzer K, Lewis J J, Churchyard G J. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis 2010; 10: 489-498.
2. Fenner L, Forster M, Boulle A, et al. Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis 2011; 15: 620-627.
3. Lawn S D, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 2011; in press.
4. World Health Organization. Guidelines for intensifi ed tuberculosis case-fi nding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/publications/2011/ 9789241500708-eng.pdf Accessed December 2010.
5. Lawn S D, Brooks S V, Kranzer K, et al. Utility of the Xpert MTB/RIF assay for screening for HIV-associated tuberculosis and rifampicin resistance prior to antiretroviral therapy in South Africa: a prospective study. PLoS Med 2011; 8: e1001067.